SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Total Current Liabilities | ₹374 Cr | ₹265 Cr | ₹179 Cr |
What is the latest Total Current Liabilities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹374 Cr |
| Mar2024 | ₹265 Cr |
| Mar2023 | ₹179 Cr |
How is Total Current Liabilities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹374 Cr | 41.19 | |
| Mar2024 | ₹265 Cr | 48.12 | |
| Mar2023 | ₹179 Cr | - | |
Compare Total Current Liabilities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹7,633.9 Cr | -9.2% | -1.7% | 60.5% | Stock Analytics | |
| PRIME FOCUS | ₹22,479.4 Cr | 7.8% | 17.6% | 82% | Stock Analytics | |
| SAGILITY | ₹19,544.6 Cr | -0.7% | 5.5% | -7.8% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹16,849.2 Cr | -0.8% | -7% | -33.9% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹14,967.8 Cr | 0.1% | -3.1% | -10.2% | Stock Analytics | |
| INDEGENE | ₹12,286.0 Cr | -0.6% | -1.2% | -10.3% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -9.2% |
-1.7% |
60.5% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses